Agilent Technologies Inc(A) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 34.64 | EPS (ttm) | 5.08 | Insider Own | 0.32% | Shs Outstand | 282.0M | Perf Week | 3.57% |
| Market Cap | 49.61B | Forward P/E | 26.22 | EPS next Y | 8.22% | Insider Trans | -0.25% | Shs Float | 281.0M | Perf Month | 1.83% |
| Enterprise Value | 51.80B | PEG | 2.65 | EPS next Q | 1.73 | Inst Own | 95.69% | Short Float | 1.86% | Perf Quarter | 25.2% |
| Income | 1.44B | P/S | 6.73 | EPS this Y | 10.94% | Inst Trans | 1.05% | Short Ratio | 2.37 | Perf Half Y | 52.19% |
| Sales | 7.37B | P/B | 6.74 | EPS next 5Y | 9.88% | ROA | 11% | Short Interest | 5.24M | Perf YTD | 29.32% |
| Book/sh | 26.11 | P/C | 28.22 | EPS past 3/5Y | 3.03% 14.68% | ROE | 20.97% | 52W High | -1.75% ($179.10) | Perf Year | 18.87% |
| Cash/sh | 6.24 | P/FCF | 39.15 | Sales past 3/5Y | 0.48% 5.41% | ROIC | 13.08% | 52W Low | 62.4% ($108.35) | Perf 3Y | 68.69% |
| Dividend Est. | $1.02 (0.58%) | EV/EBITDA | 25.31 | EPS Y/Y TTM | 19.07% | Gross Margin | 53.72% | Volatility(W/M) | 3.06% 2.82% | Perf 5Y | 11.23% |
| Dividend TTM | 1.02 | EV/Sales | 7.03 | Sales Y/Y TTM | 8.6% | Oper. Margin | 24.09% | ATR (14) | 4.93 | Perf 10Y | 305.72% |
| Dividend Ex-Date | 2026/10/6 | Quick Ratio | 1.56 | EPS Q/Q | 8.5% | Profit Margin | 19.53% | RSI (14) | 60.88 | Recom | 1.84 |
| Dividend Gr. 3/5Y | 5.63% 6.58% | Current Ratio | 2.05 | Sales Q/Q | 8.06% | SMA20 | 2.32% ($171.97) | Beta | 1.25 | Target Price | $184.11 |
| Payout | 21.7% | Debt/Eq | 0.54 | Earnings | 2026/8/26 | SMA50 | 8.64% ($161.97) | Rel Volume | 0.77 | Prev Close | $173.07 |
| Employees | 18100 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 8.85% 1.98% | SMA200 | 29.93% ($135.43) | Avg Volume(3M) | 2.21M | Price | $175.96 |
| IPO | 1999/11/18 | Option/Short | Yes/Yes | Trades | 17452 | Volume | 1,709,767 | Change | 1.67% |
🔬 A specialty analytical instruments company that supplies global life science, diagnostics, and applied analysis equipment, reagents, and software solutions. Spun off from its former parent company in 1999 and headquartered in Santa Clara, California, it is a key pillar of a global analytical instruments group that provides a wide range of analytical instruments, consumable reagents, and services to the pharmaceutical, biotechnology, food, environmental, and clinical diagnostics fields.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded less than usual. That is 77% of its average volume.
A makes money exceptionally well
Of every $100 in sales, $24.09 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.9% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $2,622. Peers typically go for $2,743. Compared with its own 5-year average, it is 15% pricier now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are roughly flat
Bought 5 years ago, your return today would be +11.2%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.58% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 95.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
FIW First Trust Water ETF 0.05% 
BEEZ Honeytree U.S. Equity ETF 0.04% 
GKAT Scharf Global Opportunity ETF 0.04% 
CVRD Madison Covered Call ETF 0.04% 
PHO Invesco Water Resources ETF 0.04% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
VOO Vanguard S&P 500 ETF 1045.4B 
IVV iShares Core S&P 500 ETF 874.5B 
QQQ Invesco QQQ Trust Series 1 475.9B 
VUG Vanguard Morningstar Growth ETF 225.1B 
VTV Vanguard Morningstar Value ETF 193.4B It ranks #4 of 44 in the industry
Based on market cap of $50B.
NTRA#3 Natera Inc $58B PER - 
A#4 Agilent Technologies Inc $50B PER 34.6 
IQV#5 IQVIA Holdings Inc $45B PER 33.9 
IDXX#6 Idexx Laboratories Inc $45B PER 40.1 
WAT#7 Waters Corp $45B PER 113.9 
Earnings Analysis · 8/26 Agilent Technologies ($A) FY2026 Q3 Earnings Analysis — Revenue and Adjusted EPS Both Beat, Full-Year Guidance Raised Investing Guides · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats Investing Guides · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is A?
A belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of A?
The market cap of A is approximately $49.6B, ranking 319 within its sector.
Does A pay dividends?
A has a dividend yield of approximately 0.58%, with an annual dividend of $1.02.
What is the P/E ratio of A?
A has a P/E ratio of approximately 34.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for A?
A has recorded a 52-week high of $179.10 and a low of $108.35.
